Nordic Capital och Avista Capital Partners innehar 80,06% av Acinos aktiekapital och fullföljer erbjudandet

For further information regarding Pharma Strategy Partners GmbH's public tender offer to the shareholders in Acino Holding AG, please see information available on www.pharmastrategypartners.com .